Literature DB >> 7907994

beta-Cyclodextrin interacts with the Alzheimer amyloid beta-A4 peptide.

P Camilleri1, N J Haskins, D R Howlett.   

Abstract

Electrospray ionisation mass spectrometry has been used to show that the synthetic 40 amino acid beta-amyloid peptide (beta 1-40) interacts with the cyclic oligosaccharide beta-cyclodextrin. This interaction, presumably with the hydrophobic aromatic moieties on the peptide, has been shown to diminish substantially the neurotoxic effects of beta 1-40 in a cell line.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907994     DOI: 10.1016/0014-5793(94)80467-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans.

Authors:  D R Howlett; A E Perry; F Godfrey; J E Swatton; K H Jennings; C Spitzfaden; H Wadsworth; S J Wood; R E Markwell
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Investigation of the noncovalent interactions between anti-amyloid agents and amyloid beta peptides by ESI-MS.

Authors:  Eric Martineau; Janna M de Guzman; Lioudmila Rodionova; Xianqi Kong; Paul M Mayer; Ahmed M Aman
Journal:  J Am Soc Mass Spectrom       Date:  2010-05-31       Impact factor: 3.109

3.  2-Hydroxypropyl-β-cyclodextrin Ototoxicity in Adult Rats: Rapid Onset and Massive Destruction of Both Inner and Outer Hair Cells Above a Critical Dose.

Authors:  Xiaopeng Liu; Dalian Ding; Guang-Di Chen; Li Li; Haiyan Jiang; Richard Salvi
Journal:  Neurotox Res       Date:  2020-06-30       Impact factor: 3.911

4.  Cyclodextrin has conflicting actions on autophagy flux in vivo in brains of normal and Alzheimer model mice.

Authors:  Dun-Sheng Yang; Philip Stavrides; Asok Kumar; Ying Jiang; Panaiyur S Mohan; Masuo Ohno; Kostantin Dobrenis; Cristin D Davidson; Mitsuo Saito; Monika Pawlik; Chunfeng Huo; Steven U Walkley; Ralph A Nixon
Journal:  Hum Mol Genet       Date:  2017-03-01       Impact factor: 6.150

5.  Energetics of cyclodextrin-induced dissociation of insulin.

Authors:  M Lovatt; A Cooper; P Camilleri
Journal:  Eur Biophys J       Date:  1996       Impact factor: 1.733

Review 6.  Beta-amyloid production, aggregation, and clearance as targets for therapy in Alzheimer's disease.

Authors:  Fernanda G De Felice; Sérgio T Ferreira
Journal:  Cell Mol Neurobiol       Date:  2002-12       Impact factor: 5.046

Review 7.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

8.  Mechanism of accelerated assembly of beta-amyloid filaments into fibrils by KLVFFK(6).

Authors:  Jin Ryoun Kim; Regina M Murphy
Journal:  Biophys J       Date:  2004-05       Impact factor: 4.033

9.  Cyclodextrins inhibit replication of scrapie prion protein in cell culture.

Authors:  Marguerite Prior; Sylvain Lehmann; Man-Sun Sy; Brendan Molloy; Hilary E M McMahon
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

10.  Per-6-substituted beta-cyclodextrin libraries inhibit formation of beta-amyloid-peptide (A beta)-derived, soluble oligomers.

Authors:  Jiaxin Yu; Lara Bakhos; Lei Chang; Mark J Holterman; William L Klein; Duane L Venton
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.